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Abstract
Background: The world has recently experienced the first influenza pandemic of the 21st century that lasted 14
months from June 2009 to August 2010. This study aimed to compare the timing, geographic spread and
community impact during the winter wave of influenza pandemic A (H1N1) 2009 to historical influenza seasons in
countries of the WHO European region.
Methods: We assessed the timing of pandemic by comparing the median peak of influenza activity in countries of
the region during the last seven influenza seasons. The peaks of influenza activity were selected by two
independent researchers using predefined rules. The geographic spread was assessed by correlating the peak week
of influenza activity in included countries against the longitude and latitude of the central point in each country.
To assess the community impact of pandemic influenza, we constructed linear regression models to compare the
total and age-specific influenza-like-illness (ILI) or acute respiratory infection (ARI) rates reported by the countries in
the pandemic season to those observed in the previous six influenza seasons.
Results: We found that the influenza activity reached its peak during the pandemic, on average, 10.5 weeks (95%
CI 6.4-14.2) earlier than during the previous 6 seasons in the Region, and there was a west to east spread of
pandemic A(H1N1) influenza virus in the western part of the Region. A regression analysis showed that the total ILI
or ARI rates were not higher than historical rates in 19 of the 28 countries. However, in countries with age-specific
data, there were significantly higher consultation rates in the 0-4 and/or 5-14 age groups in 11 of the 20 countries.
Conclusions: Using routine influenza surveillance data, we found that pandemic influenza had several differential
features compared to historical seasons in the region. It arrived earlier, caused significantly higher number of
outpatient consultations in children in most countries and followed west to east spread that was previously
observed during some influenza seasons with dominant A (H3N2) ifluenza viruses. The results of this study help to
understand the epidemiology of 2009 influenza pandemic and can be used for pandemic preparedness planning.
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The world has recently experienced the first influenza
pandemic of the 21st century that officially lasted 14
months from June 2009 to August 2010 [1]. While pan-
demic A(H1N1) 2009 influenza virus infections caused a
wide spectrum of illness, it did have a significant effect
on particular subpopulations such as pregnant women,
persons with underlying conditions, and young adults
who were at higher risk of developing severe disease
[2,3]. Where outpatient illness is concerned, there is
lack of data comparing the pandemic with previous sea-
sonal influenza outbreaks. This paper aims to compare
the timing, geographical spread and the community
effect of 2009 influenza pandemic as compared to pre-
vious seasonal influenza outbreaks in WHO European
Region.
The WHO European Region includes 53 Member
States (MS) and covers the area from Western Europe
to the Pacific coast of the Russian Federation, with a
total population of over 800 million people. Influenza
surveillance in the countries of the region is coordinated
by the WHO European Influenza Network, EuroFlu [4]
administered by the WHO Regional office for Europe.
Following its identification and emergence in North
America in March and April 2009 [5], pandemic A
(H1N1) 2009 influenza was reported to have spread to an
additional five countries by 28 April including two coun-
tries in WHO European Region: The United Kingdom
and Spain [6]. After that date, the number of reported
cases in the Region rose rapidly, and 19 countries in the
Region reported confirmed cases of pandemic influenza
by the end of May 2009. A few countries in the region
(Israel, Norway, United Kingdom, Sweden, and Malta)
experienced peaks of influenza activity before usual influ-
enza season, i.e. the week 40 of 2009.
Early reviews of pandemic data have suggested the
highest attack rates in children, followed by young adults,
with lower rates in persons over age 60 [7,8]. Studies
comparing the rates of hospitalizations and deaths from
pH1N1 to the average rates from seasonal influenza
r e v e a l e dah i g hb u r d e no ft h ed i s e a s ei nc h i l d r e na n d
working population during the 2009-2010 influenza pan-
demic in different parts of the world [2,9]. However, to
assess the magnitude of the 2009 influenza pandemic, it
is also important to assess the burden of the disease asso-
ciated with the outpatient illness. Larger numbers of
milder cases of influenza impose higher demands on
health care systems and contribute to economic costs
related to work absenteeism [10,11]. However, there are
scarce data on the effect of the 2009 influenza pandemic
on outpatient illness with some studies focused exclu-
sively on case-based surveillance [12] or presented clini-
cal consultation rates of outpatient visits during the
2009-2010 pandemic influenza season and prior seasons
without quantifying observed differences [13]. Since the
general population had limited or no immunity against
the novel A(H1N1) virus, we hypothesized that there
would be increased outpatient consultation rates asso-
ciated with influenza like illness (ILI) or acute respiratory
infections (ARI) relative to previous seasons.
In order to better understand the epidemiology of
pandemic influenza in WHO European Region, we also
analyzed the timing and geographic spread of A(H1N1)
virus in the Region in relation to those observed during
previous influenza epidemics. In particular, it was
expected that a novel virus would spread rapidly in a
susceptible population resulting in an earlier influenza
activity peak in the Region [14]. Next, the geographical
spread of novel virus might not have followed west to
east or south to north direction that is commonly
observed in the Region [15].
We used existing influenza surveillance data in coun-
tries of WHO European region to answer the following
research questions:
1. What was the timing of 2009-2010 pandemic influ-
enza season compared to previous influenza seasons?
2. What was the direction of geographic spread of
influenza virus during the pandemic season?
3. Were the total and age-specific outpatient consulta-
tion rates for ILI or ARI observed during the 2009 pan-
demic different from those observed during the seasonal
influenza outbreaks?
Methods
Data collection
Data analyzed in this paper were abstracted from the
WHO European Region database for influenza surveil-
lance (Euroflu) [4] that collects data from 46 Member
States of the WHO European Region. EuroFlu presents
epidemiological and virological data that are collected
by clinician networks and laboratory networks on a
weekly basis. The clinician networks are represented by
a stable group of general practitioners that cover a
representative sample of the general population [16].
The primary care physicians report the weekly number
of clinical cases of influenza-like illness (ILI) and/or
acute respiratory infection (ARI) to a central registry
and take respiratory specimens that are sent to a
national reference laboratory for testing. This ensures
that the clinical data reported by the sentinel physicians
are validated by virological data on influenza. Some
countries located in the central and eastern part of the
Region have a universal surveillance system, meaning
that all cases of ILI/ARI in countries with such surveil-
lance systems are reported.
ILI and ARI case definitions
The case definitions of ILI and ARI used in different
countries of the Region vary but share common criteria
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fever > 38°C, with respiratory and systemic symptoms;
the criteria for ARI are: sudden onset of respiratory
symptoms, accompanied by fever and headache in the
absence of other diagnosis. For countries reporting both
ILI and ARI rates to EuroFlu, we selected the case defi-
nition that is being used for taking specimens for virolo-
gical testing in a particular country. In addition, in some
countries reporting both rates, ILI surveillance has been
introduced relatively recently and no historical data for
ILI are available for comparisons. For such countries, we
selected ARI rates to enable comparison with historical
data.
Selection of countries
For this paper we selected all countries in the WHO
European region that have reported their weekly ILI or
ARI rates to EuroFlu for the 2009-2010 pandemic influ-
enza season and at least three past seasons. In addition,
countries should have had clear influenza activity, i.e.i n
relation to historical data and with a defined peak of
influenza activity, for at least 4 winter seasons including
the pandemic season, to be included in the analysis.
Identification of peaks of influenza activity
The analyses presented in this paper are based on iden-
tification of influenza activity peak-weeks observed dur-
ing the winter period, i.e. from week 40 to week 20. The
peak weeks of influenza activity were selected by plot-
ting the clinical and virological data available for each
country. Normally, a week with the highest consultation
rate was selected, and if two similar peaks were
observed, a peak with a higher number of influenza
virus detections was selected. If the clinical and virologi-
cal activity was very low during a season, or if it was dif-
ficult to identify the peak week, no peak was selected,
and the season was omitted from the analyses. The
identification of peak weeks was undertaken indepen-
dently by two researchers using the aforementioned
rules, and any inconsistencies were resolved through
discussion. For the Russian Federation, peaks were iden-
tified for its seven federal districts separately. For coun-
tries that observed summer and winter waves of
pandemic influenza in the season 2009-2010, the data
from winter wave were analyzed.
Assessment of timing, duration, and geographic spread
of influenza virus
To assess the timing of influenza activity in the Region,
we calculated the median peak week of influenza activity
in the Region for each of the seasons based on peak
weeks of influenza activity in each of the included coun-
tries. Next, we plotted the median peak week of influ-
enza activity in the Region, its interquartile range, and
lower and higher confidence limits for the median for
each season. The duration of influenza seasons in the
Region was calculated by subtracting the earliest and
the latest week of peak clinical activity observed in any
country. As influenza activity starts several weeks before
observing the first peak and lasts for some weeks after
the last peak, we added four weeks to the length of the
epidemic in the Region: 2 weeks before the earliest peak
and 2 weeks after the latest peak [15].
The geographic spread of influenza activity was
assessed by plotting the peak week of influenza activity
in the countries against the longitude and latitude of the
central point in each country. A squared correlation
coefficient was computed to assess the relationship
between longitude/latitudea n dt h es e q u e n c eo fi n f l u -
enza activity peak weeks in different countries. We
assessed the geographic spread of influenza virus during
the winter period, i.e. from week 40/2009 to week 20/
2010, as there were only 5 countries that experienced
peaks of influenza activity before that period, making it
impossible to analyze the course of peak activity in a
small set of countries before week 40.
For the purpose of finding the appropriate geographic
centre of a country, rounded longitude and latitude data
were used, based on the Gazetteer of Conventional
Names [18]. For the Russian Federation, the data were
analyzed on a federal district level, i.e. the longitude,
latitudes (of the federal capital city) and week of influ-
enza peak activity in each of the seven districts were
included in the analysis to ensure a detailed analysis of
the geographic spread in this large country.
We assessed the geographic spread of influenza activ-
ity for the whole Region and in two subsets of the coun-
tries in the Region. For the subset analysis, we assessed
the geographic spread in countries that are located to
the west from the longitude line of 60 degrees east and
in countries located to the west from the longitude line
of 30 degrees east. The longitude of 60 degrees East was
chosen as it marks the Ural Mountains holding the
major part of the traditional physiographic boundary
between Europe and Asia [19,20]. The longitude of 30
degrees East was chosen to investigate the geographical
spread of influenza in the western part of the WHO
European region [20], Majority of countries located in
this part of the region are Member States of the Eur-
opean Union and/or are signatory States to the Schen-
gen agreement [21]; meaning that persons in these
countries can move freely from country to country, con-
tributing to more intense interaction between popula-
tions of the countries located in this part of the Region.
Assessing the effect of the pandemic on outpatient
clinical consultation rates
To assess the effect of the pandemic on ILI/ARI clinical
consultation rates, the weekly total and age-specific
(where available) ILI or ARI rates per 100,000
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week as well as the four weeks preceding and four
weeks following the peak weeks were abstracted for
each country and season. We used simple linear regres-
sion models (with a single predictor variable being type
of influenza season, i.e. seasonal versus pandemic) to
compare clinical consultation rates for the 2009-2010
winter influenza season to the rates from seasonal influ-
enza outbreaks in each of the included countries. The
simple linear regression equation for a specific country
for the total ILI or ARI rates was following: y = a + b*x,
where “y” was the total ILI or ARI rate for a specific
country; “a” was the average ILI or ARI rate observed in
that country during the whole study period; “b” indi-
cated how much the ILI or ARI rate observed during
the pandemic season deviated from an average ILI or
ARI rate in the study period; and “x” was a binomial
variable indicating if a season was pandemic or not (0 =
pandemic, 1 = seasonal outbreak). Therefore, if b was a
positive number, it indicated that the ILI or ARI rates
observed during the pandemic were higher in relation to
previous seasons. Consequently, the negative value for b
indicated lower ILI or ARI rates observed during the
pandemic in a particular country in relation to historical
seasons included in the analyses. Separate regression
models were constructed for total and age-specific ILI/
ARI rates in each country. Age-specific analyses were
conducted for countries that provided age-specific data.
Age groups used were 0-4, 5-14, 15-64 and over 65. We
conducted all statistical analyses using SPSS version
17.0. (SPSS Statistics 17.0: Chicago)
Results
Twenty eight countries in the WHO European Region
provided their influenza surveillance for the last four or
more years and were eligible for inclusion in the study
(Figure 1). Twenty-four of these countriesp r o v i d e d
information on ILI rates, and 15 countries reported ARI
rates as an epidemiological indicator of influenza activity
in their countries (of these, 11 reported both ILI and
ARI rates). We used ILI rate for the analyses in 20
countries and the ARI rate for the remaining eight
countries (Table 1). Age-specific outpatient clinical con-
sultation rates were provided by 20 out of 28 countries.
The Figure 2 provides an example of ARI rates observed
in the Russian Federation during six influenza seasons
including the 2009-2010 pandemic season.
Timing and duration of pandemic in the WHO European
region
During the 2009-2010 pandemic influenza season, the
median influenza activity peak in the Region was
observed during the week 47. (Figure 3) There was a
perfect synchronization of influenza activity peak across
age groups during the pandemic 2009-2010 influenza
season. In most countries the age-specific peak weeks
coincided. In few countries, the peaks of influenza activ-
ity in children were observed one or two weeks earlier
than in adults. The mean difference between the median
week of influenza activity peak observed in pandemic
versus the median of historical seasons was 10.5 weeks
(95% CI 6.4-14.2). The overlapping lower and upper
confidence limits for the pandemic 2009-2010 and
2003-04 seasons indicate that the timing of influenza
peaks during these two seasons was not significantly
different.
The duration of influenza activity in the Region during
recent influenza seasons varied from 14 to 19 weeks.
The duration of influenza activity during the pandemic
season was 14 weeks, which is similar to the duration
observed during the shortest historical seasons, i.e.
2005-06 and 2006-07. The 2003-04 and 2008-09 seasons
were the longest seasons in the Region, both lasting 19
weeks.
Geographic spread of pandemic A (H1N1) virus in the
Region
During the winter wave of 2009-2010 influenza pan-
demic, the ILI and ARI consultation rates in the WHO
European Region reached their peak between week 43/
2010 England and Northern Ireland in the United King-
dom and week 50/2010 in Hungary. There was a mod-
erate correlation between longitude of country
midpoints and peak influenza activity in the western
part of Europe (R2 = 0.282, p < 0.05), indicating a west-
east spread of influenza (Table 2). However, when coun-
tries located in central and eastern parts of the WHO
60 E
3 0E
Figure 1 Countries of the WHO European Region included in
the analysis. Dark grey color indicates the countries of the Region
that are included in the analysis. Longitudes of 30 and 60 degrees
east indicate cut off values for conducting the analysis of
geographic spread in different subsets of countries.
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degrees east, were included in the analysis, the squared
correlation coefficient indicated absence of the west to
east spread pattern in these parts of the Region. (Table
2) The analysis of correlation between latitudes and
influenza activity peaks did not show south-north spread
in any part of the Region.
It is important to mention that the geographic spread
of influenza viruses in the Region followed the same
pattern in the first post pandemic, 2010-2011 influenza
season, with significant west to east spread observed
only in the western part of the region. This is in con-
trast to 2008-2009 season, when the west to east spread
was observed in all parts of the region. (Table 2) During
the 2009-2010 and 2010-2011 influenza season, the A
(H1N1) pdm09 influenza virus was the (co) dominant
virus, and in 2008-2009 influenza season, influenza A
(H3N2) was the dominant virus in the Region.
Effect of the pandemic on outpatient clinical consultation
rates
In nine (32%) out of 28 countries, the total ILI or ARI
consultation rates observed during the 2009-2010 pan-
demic season were significantly higher (p < 0.05) com-
pared to the rates observed during previous influenza
seasons (Table 3). The other countries experienced simi-
lar total rates of outpatient consultations during the
pandemic compared to historical data.
The analysis of age specific consultation rates in 20
countries with available age-specific data revealed a sig-
nificant increase in outpatient consultation rates for the
children aged 0 to 4 years in 10 (50%) countries, and for
Table 1 Countries included in the analyses and description of data used
Countries Data reported to EuroFlu Data used in the analyses Age specific data N of seasons
available*
N of seasons
included **
Albania ARI ARI no 7 7
Austria ARI & ILI ILI yes 6 5
Belgium ARI & ILI ILI yes 7 7
Czech Republic ARI & ILI ARI yes 7 6
Denmark ILI ILI yes 7 7
England ARI & ILI ILI incomplete 7 6
Estonia ARI &ILI ILI yes 5 4
France ARI ARI yes 7 7
Germany ARI ARI yes 7 6
Greece ILI ILI no 5 5
Hungary ILI ILI yes 5 5
Ireland ILI ILI yes 7 7
Italy ILI ILI incomplete 7 7
Kyrgyzstan ARI ARI no 5 4
Latvia ARI & ILI ARI yes 7 7
Netherlands ILI ILI yes 7 7
Northern Ireland ARI & ILI ILI yes 7 6
Norway ILI ILI yes 5 5
Poland ILI ILI yes 7 7
Portugal ILI ILI yes 7 6
Russian Federation ARI & ILI ARI yes 6 6
Serbia ILI ILI yes 4 4
Slovakia ARI & ILI ILI yes 7 7
Slovenia ARI ILI ILI yes 7 7
Spain ILI ILI yes 7 7
Sweden ILI ILI no 5 5
Switzerland ILI ILI no 7 7
Ukraine ARI & ILI ARI no 7 7
ILI: Influenza like illness; ARI: Acute respiratory infection
* Availability of epidemiological data in EuroFlu from season 2003-04 onwards
** depends on reporting of data by countries to EuroFlu and the presence of an outbreak with a clearly defined peak in a given season
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3) An increase in consultation rates in children was also
observed in some countries, i.e. Denmark, Netherlands,
Spain, and Slovenia, even though the total consultation
rates observed during pandemic were not significantly
higher relative to historical seasons (Table 3). Outpati-
ent consultation rates in populations aged over 65 were
significantly lower during the pandemic season com-
pared to historical data in 10 (50%) countries providing
age-specific data.
Discussion
Our study demonstrated similarities and differences in
the 2009-2010 pandemic influenza season when com-
pared to previous influenza seasons in the Region. Dur-
ing the 2009-2010 influenza season, influenza activity
peaked in the Region much earlier than in five previous
seasons. During the 2009-2010 season there were also
significantly higher clinical consultation rates of ILI/ARI
observed in younger populations. Similar to some of the
previous seasons, the influenza virus followed a west to
east direction in the western part of the Region, and the
duration of the winter wave of the pandemic influenza
was short, but similar to some other prior seasons.
The activity of pandemic influenza peaked very early
in the Region most probably due to the emergence of
the novel virus. This is consistent with the notion that
susceptibility of the population may play a more impor-
tant role that the other factors, i.e. absolute humidity
[22,23], variation in vitamin D levels related to the
amount of sunlight [24], and patterns of social mixing
[25], associated with the seasonality of influenza out-
breaks in temperate climates [26]. A similarly early peak
in influenza season in the WHO European Region was
observed during the 2003-04 season, when the Fujian
strain of A(H3N2) influenza virus was the predominant
virus circulating in Europe [27]. During this season, the
pre-existed immunity in the general population was also
limited due to a reassortment event in the A(H3N2)
influenza virus [28,29].
The duration of epidemic period in the Region during
pandemic influenza season was not shorter that during
some other recent influenza seasons. This could be par-
tially explained by the large size of the Region and a
minimum time period required for the virus to spread
to all countries. In addition, the secondary attack rate of
pandemic A(H1N1) 2009 virus has been shown to be
generally similar to the one usually observed for
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similar duration of influenza seasons.
We observed a moderate west- east spread of the
influenza virus in the Western part of the Region. In the
last eight years this direction was previously observed
during 5 historical seasons with (co) dominant and gen-
erally more virulent A (H3N2) influenza virus [33]. The
fact that this direction was observed only in the western
part of the Region during the pandemic influenza sea-
son, could be explained by more extensive air traffic in
this part of the region and its links with USA and Mex-
ico where the first cases of pandemic influenza occurred
a n ds p r e a df i r s tt ot h eS p a i na n dU n i t e dK i n g d o mi n
the Region [34]. In addition, the spread of influenza
virus in the central and especially western parts of the
region might be influenced by neighboring countries in
the Middle East and Central Asia. We did not observe
south to north spread of the virus in any parts of the
Region; this direction of spread was previously found
during a few, A(H3N2) dominated influenza seasons in
Europe [15]. Monitoring the direction of geographic
spread of influenza viruses in the region provides useful
information for planning the vaccination, allocation of
health care resources and public campaigns.
Although in most of the countries the total consulta-
tion rates were not higher when compared to historical
seasons, children in 0-4 age (in 10 countries) and in 5-
14 age groups (in 11 countries) experienced significantly
higher consultation rates compared to past data. Appar-
ently, the younger population had more limited
Figure 3 Boxplots of influenza activity timing in the WHO European Region for the recent 7 influenza seasons. The box plots present
medians, interquartile range, and the lower and upper confidence of influenza activity peak week observed in the countries of the WHO
European Region in 7 recent influenza seasons.
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compared to 65+ group in our analyses, who experi-
enced significantly lower consultation rates compared to
previous influenza seasons. This could be explained by
the previous exposure of older population to the similar
A (H1N1) viruses that circulated before the 1957 pan-
demic [35-39]. It is remarkable that during all three pre-
vious influenza pandemics of 20
th-century, older
populations appeared to be more protected compared to
children, probably due to a similar mechanism of the
presence of pre-pandemic antibodies [40].
We found that some countries in the WHO European
region experienced higher total or age-specific rates while
others did not. The health seeking behavior of the popula-
tion in different countries might have affected the rates of
outpatient consultations for ILI/ARI. However, the per-
centage of sentinel respiratory specimens tested positive
for influenza virus during the pandemic season in indivi-
dual countries is very similar to the positivity rate observed
prior the 2009 influenza pandemic [4]. This suggests that
the differences observed between different countries are
observed due to the stochastic nature of influenza spread.
Differences in impact in different countries are typical for
influenza pandemics [40], and could be explained by the
heterogeneity in the degree of immunity in local popula-
tions to the pandemic influenza virus, as well as by differ-
ences in transmission factors such as local geographic
conditions and patterns of social mixing.
Strengths and limitations of the study
To our knowledge, this is the first study comparing the
timing, geographic spread and outpatient clinical
consultation rates for ILI or ARI of the 2009-2010 pan-
demic influenza season against historical data for a large
number of countries. We used routine sentinel surveil-
lance data, and it has been shown that both ILI and ARI
consultations rates provided by countries with sentinel
surveillance systems are reliable estimates of influenza
activity, e.g. peaks of influenza activity based on ILI or
ARI rates are well supported by virological confirma-
tions [15]. Another strong point of the analysis is inclu-
sion of data for 2003-04 influenza season, during which
the predominant A(H3N2) virus caused higher consulta-
tion rates in children of 0-4 age in several countries
[41].
Sentinel ILI/ARI surveillance data that were used for
the current analyses, are collected systematically from a
standard number of sites, thereby enhancing the com-
parability of the 2009-2010 data to those from historical
seasons. Although three countries (Kyrgyzstan, the Rus-
sian Federation, and Ukraine) in these analyses provided
non sentinel epidemiological data, considering that these
countries have universal ARI surveillance systems that
have been operating for many years, i.e.a l lA R Ic a s e s
are being routinely reported, we expect the data pro-
vided by these countries to reliably represent influenza
activity in their countries.
Although the case definitions for ILI or ARI used by
countries are differing, it is important to highlight that
f o rt h i sa n a l y s i sn ob e t w e e n - c o u n t r yc o m p a r i s o n sh a v e
been made. Instead, data from each of the included
countries were compared over the time. When compar-
ing outpatient consultation ILI or ARI rates in each of
the countries, we assumed that there were no changes
Table 2 Spread of pandemic (H1N1) virus in WHO European Region during 2008-09, 2009-2010, and 2010-2011
influenza seasons
Season W-E R
2 S-N R
2 N of countries †
2010-2011
Western part of the WHO European region § 0.244* 0.040 36
Western and central parts of WHO European region ‡ 0.080 0.030 45
WHO European region 0.002 0.000 51
2009-2010
Western part of the WHO European region § 0.282* 0.037 26
Western and central parts of WHO European region ‡ 0.088 0.043 30
WHO European region 0.001 0.051 35
2008-2009
Western part of the WHO European region § 0.731* 0.000 25
Western and central parts of WHO European region ‡ 0.852* 0.020 34
WHO European region 0.330* 0.002 39
† Federal districts in the United Kingdom and the Russian Federation referred as separate countries in this analysis
*significant at 0.05 level
W-E west to east spread; S-N south to north spread; R
2: squared correlation coefficient
§ countries located before longitude line of 30 degrees east
‡ countries located before longitude line of 60 degrees east
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affected the consultation rates over the time. However,
the ILI or ARI rates in some of the countries might
have been influenced by media bias, i.e. attention that
had been paid to the influenza pandemic by mass media
could have affected the health seeking behavior resulting
in higher consultation rates. Since we have based our
analysis on the winter wave of the pandemic and we
have excluded the ILI or ARI rates observed during the
summer wave, when the consultation rates were most
likely to be affected by media bias or panic [42], we
expect less influence on health seeking behavior during
the winter wave of the pandemic. On the other hand, a
variety of prevention measures had been undertaken by
Table 3 Comparison of total and age-specific ILI or ARI consultation rates observed during the pandemic in relation to
previous influenza seasons
Country Ŧ Age specific and total regression coefficients ‡
0-4 5-14 15-64 Over 65 Total
All ages affected
Norway 0.666* 0.667* 0.555* 0.325* 0.606*
Children and working population affected
Ireland 0.815* 0.816* 0.641* 0.063 0.746*
Northern Ireland 0.638* 0.748* 0.465* -0341* 0.588*
Children affected
Russian Federation 0.540* 0.680* 0.436 -0.436 0.606*
Estonia 0.538* 0.515* 0.223 -0.072 0.407*
Netherlands 0.400* 0.414* 0.022 -0,286* 0.107
Spain 0.358* 0.488* 0.056 -0.147 0.234
Portugal 0.375* 0.520* -0.179 -0.272* -0.60
Denmark 0.271* 0.328* 0.115 -0.204 0.157
Latvia 0.296* 0.110 -0.203 -0.379* -0.102
Austria -0.052 0.345* -0.123 -0.424* -0.026
Slovenia -0.071 0.353* 0.038 -0.033 0.133
No effect
Belgium 0.034 0.184 -0.026 -0.216 0.121
Poland 0.047 0.115 0.052 -0.151 0.048
Czech Republic -0.172 0.024 -0.253 -0.394* -0.216
France 0,076 -0.193 -0,117 0.011 -0.057
Germany -0.267 0,126 0.006 -0.305* -0.053
Poland -0.013 0.068 0.003 -0.203 -0.003
Serbia -0.157 0.121 0.127 -0.472* 0.033
Slovakia -0.304* -0.186 -0.314* -0.399* -0.297*
Switzerland n.a. n.a. n.a. n.a. 0.207
Ukraine n.a. n.a. n.a. n.a. 0.048
Albania n.a. n.a. n.a. n.a. -0.122
Italy n.a. n.a. n.a. n.a. -0.282
Significant overall effect
Sweden n.a. n.a. n.a. n.a. 0.358*
Greece n.a. n.a. n.a. n.a. 0.303*
Kyrgyzstan n.a. n.a. n.a. n.a. 0.332*
England n.a. n.a. n.a. n.a. 0.295*
The regression coefficients compare the total and age-specific ILI (influenza like illness) or ARI (acute respiratory infection) rates observed during the peak week
of influenza activity, four weeks preceding the peak and four weeks following the peak in each of the countries
Ŧ Ranking is based on the regression coefficient for 0-4 age group
‡ a positive regression coefficient means that the rate observed during the pandemic was higher compared to the historical seasons; a negative regression
coefficient means that the rate observed during the pandemic was lower compared to the historical seasons
*significant at p < 0.05
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Page 9 of 11countries during the pandemic influenza season, includ-
ing vaccination, social distancing, school closures, anti-
viral treatment and prophylaxis that might have reduced
the attack rates [43-45], and subsequently the outpatient
consultation rates due to ILI or ARI. If these measures
had not been undertaken, we might have observed a
greater difference between pandemic and seasonal ILI/
ARI rates in the countries of the Region.
The availability of surveillance systems for outpatient
consultations rates allowed monitoring of influenza
activity during the pandemic in the region and enabled
this analysis to improve our understanding of epidemiol-
ogy of the 2009 pandemic. However, there was no sys-
tematically collected data regarding hospitalization
across the Region during the previous seasons to enable
comparative analysis of risk factors for severe acute
respiratory infections. Establishment of such systems in
the countries of the WHO European Region is ongoing
[46] and will improve greatly surveillance of future influ-
enza outbreaks.
Conclusion
In conclusion, we found that the 2009-2010 influenza
pandemic in WHO European region had an epidemiolo-
gical signature that was both similar and different to
seasonal influenza epidemics since 2003 in the European
Region. The 2009-2010 pandemic was similar length to
previous seasonal epidemics and followed a west-east
progression in western part of the Region that has been
previously observed, albeit in seasons with dominant for
A (H3N2) influenza virus. However, the 2009-2010 sea-
son arrived earlier than any season observed since the
emergence of the “Fujian” H3 variant during 2003-04
influenza season, and had a uniquely strong impact on
ILI/ARI clinical consultation rates among children.
These results add to the growing body of knowledge
about pandemic A (H1N1) 2009 that may be used for
future pandemic preparedness across the Region.
Disclaimer
Maps used in this paper do not imply any opinions
whatsoever on the part of WHO or its partners about
the legal status of the countries and territories shown or
about their borders.
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